Atlas Trials

A Study of LY3819469 in Participants With Impaired and Normal Renal Function

Clinical trial NCT05841277 · COMPLETED

Trial details

NCT number
NCT05841277
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal InsufficiencyHealthy
Start date
2023-04-25
Primary completion
2024-01-09
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.